يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
Barclays Maintains Equal-Weight on PTC Therapeutics, Raises Price Target to $46
PTC Therapeutics, Inc. -1.09%
PTC Therapeutics, Inc. PTCT | 75.42 | -1.09% |
Barclays analyst Gena Wang maintains PTC Therapeutics (NASDAQ:
PTCT) with a Equal-Weight and raises the price target from $42 to $46.
